1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. GYRE THERAPEUTICS INC
Gyre Therapeutics Inc XNAS: GYRE
7.85 -0.20 (-2.48%)
65,577
XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Gyre Therapeutics Inc - GYRE - stock price prediction, stock price target, analyst ratings from 3 analysts

Gyre Therapeutics Inc has a share price target of US$ 18, revenue growth forecast of 9.4%, and profit growth estimate of 6.7% for FY25, based on top 3 analyst calls.